OR7L1P

Across TCGA pan-cancer cohorts, OR7L1P RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of OR7L1P’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where OR7L1P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types OR7L1P is over-expressed in tumor.

HNSC, LUAD, and LUSC are the cancer types where OR7L1P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in OR7L1P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	Male	II,III,IV	+0.072	.001	8	view →
LUAD	All	All	+0.099	.009	4	view →
LUSC	All	All	+0.136	<.001	3	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

OR7L1P–HNSC

Open the HNSC breakdown →